Paper42653701
Hepatotoxicity Profile of Bortezomib-Containing Regimens for First-Line Multiple Myeloma Treatment.
Lucijanic M and 6 others. Pharmaceuticals (Basel), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Hepatotoxicity Profile of Bortezomib-Containing Regimens for First-Line Multiple Myeloma Treatment. Papers, record 42653701. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42653701
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hepatotoxicity Profile of Bortezomib-Containing Regimens for First-Line Multiple Myeloma Treatment.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15738379 | Bortezomib-induced severe hepatitis in multiple myeloma: a case report. | Arch Intern Med | 2005 | https://conductscience.org/library/papers/15738379 | PubMed |
| 2 | 18753647 | Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18753647 | PubMed |
| 3 | 22462599 | Bortezomib-associated fatal liver failure in a haemodialysis patient with multiple myeloma. | Clin Toxicol (Phila) | 2012 | https://conductscience.org/library/papers/22462599 | PubMed |
| 4 | 33527986 | Renohepatic crosstalk: a review of the effects of acute kidney injury on the liver. | Nephrol Dial Transplant | 2022 | https://conductscience.org/library/papers/33527986 | PubMed |
| 5 | 16855634 | International uniform response criteria for multiple myeloma. | Leukemia | 2006 | https://conductscience.org/library/papers/16855634 | PubMed |
| 6 | 17699366 | Light-chain (AL) amyloidosis: diagnosis and treatment. | Clin J Am Soc Nephrol | 2006 | https://conductscience.org/library/papers/17699366 | PubMed |
| 7 | 4025319 | Liver involvement in multiple myeloma. | Am J Hematol | 1985 | https://conductscience.org/library/papers/4025319 | PubMed |
| 8 | 29931775 | Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies. | Cancer Med | 2018 | https://conductscience.org/library/papers/29931775 | PubMed |
| 9 | 27511158 | International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. | Lancet Oncol | 2016 | https://conductscience.org/library/papers/27511158 | PubMed |
| 10 | 20368561 | Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20368561 | PubMed |
| 11 | 40325790 | Evolution of treatment practices and outcomes in multiple myeloma during 2013-2022: a Finnish real world registry study. | Acta Oncol | 2025 | https://conductscience.org/library/papers/40325790 | PubMed |
| 12 | 2254635 | Criteria of drug-induced liver disorders. Report of an international consensus meeting. | J Hepatol | 1990 | https://conductscience.org/library/papers/2254635 | PubMed |
| 13 | 40032738 | Extramedullary disease in multiple myeloma at diagnosis and over the course of the disease. | Int J Hematol | 2025 | https://conductscience.org/library/papers/40032738 | PubMed |
| 14 | 15958804 | Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15958804 | PubMed |
| 15 | 19766729 | Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. | Biol Blood Marrow Transplant | 2010 | https://conductscience.org/library/papers/19766729 | PubMed |
| 16 | 26861310 | Hepatotoxicity by Drugs: The Most Common Implicated Agents. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/26861310 | PubMed |
| 17 | 25439696 | International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. | Lancet Oncol | 2014 | https://conductscience.org/library/papers/25439696 | PubMed |
| 18 | 28453614 | Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Ann Oncol | 2017 | https://conductscience.org/library/papers/28453614 | PubMed |
| 19 | 39350738 | Drug metabolism and transport mediated the hepatotoxicity of Pleuropterus multiflorus root: a review. | Drug Metab Rev | 2024 | https://conductscience.org/library/papers/39350738 | PubMed |
| 20 | 41588065 | Real-world analysis of multiple myeloma treatments in England using the Cancer Analysis System registry. | Sci Rep | 2026 | https://conductscience.org/library/papers/41588065 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| ATHS | 470 | PubTator's text mining | https://conductscience.org/library/genes/470 | NCBI Gene |
| GGTLC5P | 653590 | PubTator's text mining | https://conductscience.org/library/genes/653590 | NCBI Gene |
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42653701
GET https://conductscience.org/api/papers/v1/42653701/references?page=2